The Dental Crowns and Bridges Market is likely to gain momentum from the rising usage of digital dentistry. Presently, masses at are choosing various digital equipment, such as milling machines, computer software, scanners, and radiological devices for restorative and preventive dentistry. Teeth structures are also being customized by using CAD/CAM, as well as 3D printing technologies. This information is published by Fortune Business Insights™ in a recent report, titled, “Dental Crowns and Bridges Market Size, Share & Industry Analysis, By Type (Crowns, and Bridges), By Material (Ceramics, Porcelain Fused to Ceramics, and Metals), By End User (Dental Hospitals & Clinics, Dental Laboratories, and Others), and Regional Forecast, 2019-2026.” The report further mentions that the Dental Crowns and Bridges Market size was USD 2.85 billion in 2018 and is projected to reach USD 4.56 billion by 2026, exhibiting a CAGR of 6.1% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/dental-crowns-and-bridges-market-102714

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

Fortune Business Insights™ presents a list of all the organizations operating in the Dental Crowns and Bridges Market. They are as follows:

• Dentsply Sirona
• Institut Straumann AG
• Nobel Biocare Services AG (Danaher)
• National Dentex Lab
• Henry Schein, Inc.
• Ivoclar Vivadent AG
• 3M
• Glidewell
• Dentium
• Zimmer Biomet
• BIOTECH Dental
• Others

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/dental-crowns-and-bridges-market-102714

Ability to Provide Lucent Finish will Drive Growth of the Ceramics Segment

Based on material, the market is grouped into metals, porcelain fused to metals, and ceramics. Out of these, the ceramics segment held 55.2%Dental Crowns and Bridges Market share in 2018 and is anticipated to remain dominant throughout the forecast period. This growth is attributable to the ability of ceramics to provide an attractive lucent finish to bridges and crowns.

Regional Analysis-

Rising Geriatric Population to Favor Growth in Europe

Geographically, the market is divided into the Middle East and Africa, Europe, Latin America, North America, and Asia Pacific. Amongst these, Europe procured USD 1.16 billion Dental Crowns and Bridges Market revenue in 2018. This growth is attributable to the higher adoption of digital dentistry equipment, surging dental expenditures, and rising geriatric population. Also, increasing and treatment and diagnosis rate for various dental disorders would propel growth of the market in this region.

The global medical clothing market is set to gain momentum from the rising incidence of hospital-acquired infections. Besides, the rising awareness campaigns regarding the benefits of clinical clothing would affect the market positively. Fortune Business Insights™ provided this information in a recent report, titled, “Medical Clothing Market Size, Share & Industry Analysis, By Product (Surgical Drapes, Medical Scrubs and Gowns, Gloves, Facial Protection, Sterilization Wraps, Protective Apparels and Others), By Application (Hospitals & Physicians’ Offices, Outpatient Facilities, and Others), and Regional Forecast, 2020-2027.” The report further states that the medical clothing market size was USD 63.3 billion in 2019 and is projected to reach USD 99.9 billion by 2027, exhibiting a CAGR of 5.9% during the forecast period.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/medical-clothing-market-102704

Fortune Business Insights™ lists out the names of organizations present in the global market. They are as follows:

• Cardinal Health, Inc.
• Halyard Health
• 3M Company
• Medline Industries, Inc.
• Superior Uniform Groups
• Semperit AG Holding
• Ansell Healthcare LLC
• Medline Industries
• Mölnlycke Health Care
• Barco Uniforms
• Other prominent players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/medical-clothing-market-102704

Segment-

Surgical Drapes, Scrubs and Gowns Segment to Lead Fueled by its Usage in Multiple Healthcare Institutions

In terms of product, the market is divided into protective apparel, sterilization wraps, facial protection, gloves, surgical drapes and gowns, and others. The surgical drapes and gowns segment held 33.0% medical clothing market share in 2019. This growth is attributable to their rising usage in multiple healthcare institutions stoked by their ability to protect the staff from blood-borne pathogens of the patients. Coupled with this, increasing technological advancements, rising hygiene awareness, surging patient pool, and rising awareness regarding infections would contribute to the growth of this segment.

Regional Analysis-

North America to Remain at the Forefront Stoked by Developed Healthcare Infrastructure

The market is geographically fragmented into the Middle East and Africa, Europe, Latin America, Asia Pacific, and North America. Amongst these, North America procured USD 25.5 billion in 2019 and is set to dominate in the forthcoming period. This growth is attributable to the presence of numerous medical clothing manufacturing companies, increasing prevalence of acute and chronic diseases, and developed healthcare infrastructure. Asia Pacific, on the other hand, is estimated to grow rapidly by exhibiting high CAGR on account of the increasing awareness programs amongst the masses regarding hygiene and safety.

The global wound care market size is projected to showcase significant progress and earn USD 24.55 billion by 2027. This is accountable to the increasing prevalence of chronic diseases such as diabetes, blood pressure, and the wounds that result from them, such as diabetic foot ulcers and pressure ulcers. Wound care is used for injuries that are unable to heal by themselves. If untreated, they may result in severe consequences, such as mobility issues, decreased elasticity of blood vessels, and others. A recent report by Fortune Business Insights offers an elaborative overview of the market. The report is titled, “Wound Care Market Size, Share & Covid-19 Impact Analysis, By Type (Advanced Wound Dressing, Traditional Wound Care Products, Negative Pressure Wound Therapy, Bioactives, and Others), By Application (Chronic Wounds, and Acute Wounds), By End User (Hospitals, Clinics, Homecare Settings, and Others), and Regional Forecast, 2020-2027.” According to this report, the market value stood at USD 15.68 billion in 2019 and is likely to exhibit a CAGR of 6.0% between 2020 to 2027.

Please visit: https://www.fortunebusinessinsights.com/wound-care-market-103268

As per a report by Fortune Business Insights™, some of the significant players in the market are as follows:

• Johnson & Johnson Services, Inc.
• Smith & Nephew
• Coloplast Corp
• Cardinal Health
• ConvaTec Inc.
• Medtronic
• 3M
• BSN Medical (Essity)
• PAUL HARTMANN AG
• Other players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/wound-care-market-103268

Drivers & Restraints-

Increasing Popularity of Bioactive Therapy to Add Impetus to Market

The rising prevalence of acute and chronic diseases such as diabetic foot ulcers, pressure ulcers, and others are some of the key factors promoting this market growth. This, coupled with the advent and adoption of technologically advanced wound care products, will also add impetus to the market. Additionally, continuous research and development, as well as increasing investments in the launch of advanced wound care products are likely to bolster growth in the coming years.

On the contrary, high treatment costs and the presence of limited or no reimbursement policies, especially in the underdeveloped nations, may challenge the growth of the market. Nevertheless, the advent of bioactive therapy for treating chronic wounds is expected to create a lucrative growth opportunity for the market in the coming years

 Segment:

Advanced Wound Dressing Segment to earn Largest Share Owing to Better Product Offering

Based on segmentation by type, the advanced wound dressing segment earned 42.6% wound care market share in 2019 and emerged dominant. This is owing to the presence of a diverse product portfolio.

 The global telerehabilitation market size is poised to rise remarkably in the coming years attributable to the technological advancements in the field of healthcare services in collaboration with information, technology, and communications. Telerehabilitation is a medical service for people preferring to stay at home and avail treatment and services. As per a recent report by Fortune Business Insights, titled, “Telerehabilitation Market Size, Share and Covid-19 Impact Analysis, By Type (Products, Services), By Application (Occupational Therapy, Physical Therapy, Chronic Diseases, and Others), By End-User (Healthcare Facilities and Homecare); and Regional Forecast, 2020-2027,” the market value stood at USD 3.32 billion in 2019 and is expected to rise at a CAGR of 13.4% to reach USD 9.13 billion by 2027. The forecast period is set between 2020 to 2027.

Please visit: https://www.fortunebusinessinsights.com/telerehabilitation-market-103112

As per Fortune Business Insights™, some of the significant players in this market include:

• MIRA Rehab Limited (UK)
• (United States)
• Doctor On Demand, Inc. (United States)
• Care Innovations, LLC. (United States)

• American Well (United States)
• NeoRehab
• Hinge Health, Inc. (United States)
• Koninklijke Philips N.V. (Netherlands)
• Other players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/telerehabilitation-market-103112

Drivers & Restraints-

Increasing Geriatric Population Vulnerable to Various Diseases will Promote Growth

Telerehabilitation can address a wide variety of medical services through the means of telecommunication and technology. This is especially helpful in the case of patients residing in remote locations with mobility issues and for the aged population. The increasing geriatric population is a key factor promoting the telerehabilitation market growth. Additionally, a rise in the patient pool for chronic diseases is also set to aid in the expansion of the market in the coming years.

Segment:

Services Segment to Gain Significant Position Owing to Increasing Number of Service Providers:

Based on segmentation by type, the services segment dominated the market in 2019 on account of the rising adoption of telerehabilitation services and the increasing number of service providers.

Regional Analysis-

North America Earned Dominance Owing to Presence of Advanced Healthcare Technologies

North America earned the highest telerehabilitation market share on account of the rising adoption of telehealth services, presence of advanced medical services, and increasing inclination towards virtual consultation. This, coupled with the increasing number of geriatric population, their vulnerability to various diseases, and a rise in the number of e-visits are likely to help this region continue dominating the market in the coming years.

The global home infusion therapy market size is likely to USD 86.89 billion by the end of 2027 owing to the increasing adoption of home medical services worldwide. In a home infusion therapy setting, a patient receives all medical assistance at home including drugs and biologics via a subcutaneous or an intravenous administrative route. According to a recent report by Fortune Business Insights titled, “Home Infusion Therapy Market Size, Share & Industry Analysis, By Product (Devices, Drugs, and Services) By Indication (Anti-Infective, Chemotherapy, Hydration Therapy, Enteral Nutrition, Total Parenteral Nutrition, Immunoglobulin Therapy, and Others), and Regional Forecast, 2020-2027,” the value of this market was USD 27.25 billion in 2019 and is expected to grow at a CAGR of 2.2% between 2020 and 2027.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/home-infusion-therapy-market-102989

Fortune Business Insights™ lists out the names of market manufacturers. They are as follows:

• Optum, Inc.
• Infusystem
• Option Care Health Inc.
• Moog Inc.
• CareCentrix, Inc.
• Braun Melsungen AG
• Lincare Holdings Inc.
• Baxter
• Promptcare
• BriovaRx Infusion Services
• Other players

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/home-infusion-therapy-market-102989

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this, too, shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. Some industries are struggling, and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

Segment-

Drugs Segment to Hold Dominance Owing to Increasing Incidences of Cancer

Based on segmentation by product, the drugs segment earned the highest home infusion therapy market share on account of the increasing number of immune diseases worldwide and the rising prevalence of cancer. Besides this, the devices segment earned a 6.6% share and is likely to witness significant growth in the coming years on account of increasing technological advancements in the delivery of home medication system for various purposes.

Regional Analysis-

North America to Dominate Market on Account of Rising Adoption of Innovative Technologies

Regionally, North America emerged at the top with a revenue of USD 10.53 billion in 2019. The growth of this region is attributable to the development of delivery devices for home medication and its increasing adoption. Besides this, the rising number of patients and rapid adoption of the latest technologies are factors responsible for the dominance of this region.

According to the World Bank, approximately 84% populace in Germany depend on Internet and around 75% populace in the U.S. are subscribers of the Internet, which augments the global ePharmacy market growth. Fortune Business Insights states that the global ePharmacy market is projected to reach US$ 177,794.9 Mn by 2026, thereby exhibiting an impressive CAGR of 17.3% during the forecast period (2019-2026). The company further states that the global market was valued at US$ 49,727.7 Mn in 2018. According to a published report by Fortune Business Insights, titled, “ePharmacy: Global Market Analysis, Insights and Forecast, 2019-2026,” the global ePharmacy market will witness notable growth during the forecast period due to the technological advancements based on artificial intelligence.

Browse Complete Report Details@ https://www.fortunebusinessinsights.com/industry-reports/epharmacy-market-100238

Fortune Business Insights has profiled some of the prominent market players operating in the global ePharmacy market. They are as follows:

• DocMorris
• CVS Health Corporation
• Express Script Holding Company
• Walgreen Co.
• Optum Rx, Inc.
• Giant Eagle, Inc.
• Walmart Stores, Inc.
• Rowland Pharmacy
• The Kroger Co.
• Other players

Get PDF Brochure of this Report@ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/epharmacy-market-100238

Increasing Adoption of E-commerce Websites to Favor Growth in Asia Pacific

Geographically, the global ePharmacy market is grouped into Asia Pacific, North America, the Middle East and Africa, Europe, and Latin America. Out of these regions, North America is expected to remain in the leading position in the global ePharmacy market during the forecast period. The growth is attributed to the rapid shift of consumers towards online retailers from offline pharmacies. Also, increasing usage of smartphones and high speed of the Internet are expected to aid North America in gaining the highest global ePharmacy market share in the forthcoming years. Furthermore, a rise in geriatric population, increasing online orders, and growing adoption of online platforms will drive the market growth in this region.

Europe and Asia Pacific, on the other hand, are projected to exhibit significantly high CAGR during the forecast period. In Europe, numerous prominent market players have begun offering products at lucrative rates. This will positively impact growth of ePharmacy market in this region. Asia Pacific, on the other hand, has been witnessing higher adoption of e-commerce websites and increasing patient pool. Moreover, the healthcare infrastructure in this region is on the verge of becoming prosperous. All these factors are anticipated to fuel ePharmacy market growth in Asia Pacific in the coming years.

Some major points from Table of Content:

1. Introduction
   • Research Scope
   • Market Segmentation
   • Research Methodology
   • Definitions and Assumptions
2. Executive Summary
3. Market Dynamics
   • Market Drivers
   • Market Restraints
   • Market Opportunities
4. Key Insights
   • Key Start-ups and Funding Overview
   • Key Industry Developments – Mergers, Acquisitions, and Partnerships, 2018
   • Overview of Regulatory Scenario – Key Countries
   • Key Industry Trends
   • Overview of e-Commerce Penetration – Key Countries

TOC Continued….

The Global Burden of Disease Study has found that around 251 million people in the world were affected by Chronic Obstructive Pulmonary Disease or COPD in 2016. This will fuel demand for nebulizers, driving the global nebulizers market. The above information was shared by Fortune Business Insights in a report, titled “Nebulizers Market Size, Share and Global Trend By Product (Pneumatic Nebulizers, Ultrasonic Nebulizers, Mesh Nebulizers, Others), By End-User (Clinics, Hospitals, Ambulatory Surgery Centres, Home Care Settings, Others), and Geography Forecast till 2026.” A nebulizer is a medical device which helps to treat asthma by converting different drugs into vapours and later delivering it to the lungs. Not only asthma, but nebulization also helps in the treatment of other respiratory disorders such as cystic fibrosis. 

The demand for different types of nebulizer products such as ultrasonic nebulizers, pneumatic nebulizers, mesh nebulizers, and others is increasing. Of these, a pneumatic nebulizer was leading the global market and is anticipated to maintain its dominance through the forecast years. The rising prevalence of respiratory disorders especially among the aged population is driving the segment’s growth. Considering this, the global nebulizers market share is expected to increase in the forecast years.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/nebulizers-market-100707

some of the key players in the Global Nebulizers Market:

• OMRON Corporation
• Koninklijke Philips N.V.
• PARI
• Becton
• Dickinson and Company
• Allied Healthcare
• Agilent Technologies, Inc.
• Medline Industries, Inc.
• Briggs Healthcare

Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/nebulizers-market-100707

Market Sees Growth Owing to Rising Adoption of Technologically-advanced Medical Devices in North America

Rising geriatric population in North America is resulting in an increasing number of surgeries and respiratory diseases. This will boost the nebulizers market size in North America. As per a study conducted by the Center for Diseases Control and Prevention, people in the U.S. suffered deaths in 2014, as COPD was the third-leading disease for these deaths. The market was leading in the year 2018 on account of mounting pollution levels and increasing healthcare expenditure. Another factor responsible for growth is the rising adoption of technologically-advanced medical devices and equipment.

The market in Asia Pacific is expected to grow considerably during the forecast period. Increasing cases of respiratory disorders and rising geriatric population are primary factors enabling growth in the market. Countries such as India and China have high pollution levels, which increases the prevalence of respiratory diseases. Enabled by this, the demand for nebulizer machines is increasing in Asia Pacific. This will further positively impact nebulizers market growth. Rising disposable income among people and growing awareness about diseases in this region are potential growth triggers in the market. As per the Institute for Health Metrics and Evaluation, the number of COPD cases in Japan increased by 24.2% between 2005 and 2016. Hence, the rising prevalence of respiratory disorders is expected to drive the nebulizers market size in Asia Pacific.

The increasing prevalence of respiratory diseases and alpha-1 antitrypsin deficiency among people worldwide is boosting the global plasma fractionation market, says Fortune Business Insights in a new study. The report, titled “Plasma Fractionation: Global Market Analysis, Insights, and Forecasts 2018 to 2026,” offers insights into growth drivers and restraints impacting the plasma fractionation market.

Browse Complete Report:

https://www.fortunebusinessinsights.com/industry-reports/plasma-fractionation-market-101614

List of the companies functioning in the global market are

• LFB
• Shire
• Japan Blood Products Organization
• Biotest AG
• Grifols, S.A.
• C. Pharma (Green Cross Corporation)
• Octapharma
• Sanquin
• Kedrion S.p.A.
• Baxter
• China Biologic Products
• CSL
• Shanghai RAAS Blood Products

Get Sample PDF:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/plasma-fractionation-market-101614

Rise in Number of Diagnostic Centers for using Plasma Proteins as Therapeutics to Bode Well for Market

The rising awareness about diseases because of the expansion of media and increasing number of diagnostic centers have increased the value of plasma fractionation. This is a major factor boosting the overall market. In addition to that, increasing investments made in designing of therapeutics for chronic diseases is also anticipated to drive the global market. Besides this, the increasing popularity and usage of proteins derived from plasma for various treatments is presumed to bode well for the global market.

However, high cost of fractionation and insufficient reimbursement policies may cause hindrance to the growth of the market. This, accompanied by the emergence of recombinant alternatives may hamper the market in the long run.

North America Emerges Dominant on Account of Better Healthcare Infrastructures

Geographically, the global market for plasma fractionation is dominated by North America at present. Factors promoting growth in this region are better healthcare infrastructures, government supported reimbursement policies, and presence of large company in developed nations of the region namely Canada and the U.S. Moreover, recent approvals from the Food and Drug (FDA) favor the growth of new plasma fractionation facilities are thus creating lucrative growth opportunities for the market in North America. For instance, the FDA approved a plasma fractionation facility in Melville for Kedrion S.P.A. in February 2019.

The “Telehealth Market Growth” is likely to expand considerably with impetus from the ability of telehealth to serve the rural population. According to a report published by Fortune Business Insights, titled “Telehealth: Global Market Analysis, Insights, and Forecast, 2019-2026,” The Global Telehealth Market was valued at US$ 49.8 Bn in 2018. Fortune Business Insights has predicted that the market will reach US$ 266.8 Bn by 2026, thereby exhibiting a CAGR of 23.4%.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/telehealth-market-101065

Key Players Operating in The Telehealth Market Include:

Key players are involved in mergers and acquisition to strengthen their market position. Owing to increasing competition frequent innovations are taking place in the market. Some of the companies operating the industry are:

• Dictum Health, Inc.
• SnapMD, Inc.
• American Well
• MDLIVE Inc.
• GlobalMed
• Doctor on Demand, Inc.
• Encounter Telehealth
• Teledoc Health, Inc.

Highlights of the Report:

• In-depth analysis of various insights, namely, Telehealth Market trends, growth drivers, opportunities, and other related challenges.
• Comprehensive details of key market players, their core competencies, and Telehealth Market share.
• The potency of suppliers and buyers to make better business decisions.
• Lists out the market size in terms of volume.

Request a Sample Copy of Market Research Report : https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/telehealth-market-101065

Technological Advancements to Fuel Demand for Telehealth Services

The technological advancements in telehealth products and services have fuelled the demand for telehealth services across the world. The advent of user-friendly systems has contributed to a high demand, which in turn has led to an increase in the global telehealth market value in recent years. In 2019, InTouch announced the launch of a fully integrated end-to-end virtual platform aimed at providing enhanced patient care solutions. ‘Solo’ was a flexible platform integrated with services such as enhanced emergency care solutions, direct-to-patient, and direct-to-customer, which in turn will contribute to the growth of the global telehealth market in the coming years.

Preference for Online Consultation to Favour the TelehealthMarket in North America

Among regions, North America is expected to dominate the global telehealth market share during the forecast period. The main factors driving the market in the region is the increasing inclination towards online medical consultation and a well-established healthcare insurance system in the continent. Rising popularity of wearable devices is anticipated to be the primary force behind the telehealth market growth in Europe. In Asia-Pacific, government schemes and increasing investment in healthcare brings good news for the market in the forecast period. Increasing healthcare spending in the Middle East and high concentration of population in rural areas will be the main factors augmenting the telehealth market growth till 2026.

The global hereditary angioedema treatment market to gain from increasing incidences of genetic mutation. Recently Fortune Business Insights, published a report titled, “Hereditary Angioedema Treatment Market Size, Share and Global Trend by Drug Class (C-1 Esterase Inhibitors, Bradykynin Receptor Antagonist, Kallikrein Inhibitors), Application (Prophylaxis, Treatment), Route of Administration (IV, Subcutaneous), Distribution Channel (Hospital Pharmacy, Retail Pharmacy) and Geography Forecast till 2025.” As per the report, the global hereditary angioedema treatment market was worth US$ 1883.1 Mn in 2017. The global market is anticipated to expand at a CAGR of 16.8% and reach US$ 6533.3 Mn by the end of 2025. The report classifies the global hereditary angioedema treatment market in various segments and offer a comprehensive overview.

For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/hereditary-angioedema-treatment-market-100164

some of the key players in the global Hereditary Angioedema Treatment Market:

• BIOCRYST PHARMACEUTICALS INC.
• Ionis Pharmaceuticals Inc.
• Attune Pharmaceuticals
• Arrowhead Pharmaceuticals Inc.
• Adverum

According to the report, the hereditary angioedema treatment market in North America was valued at US$ 1752.2 Mn in 2017. The growth witnessed is attributable to high prevalence of hereditary angioedema in the region. North America may remain dominant in the global market through the forecast period (2018-2025) also. Presence of an established healthcare system and increasing healthcare expenditure are a few factors anticipated to contribute the expansion of the hereditary angioedema treatment market in North America. The report also predicts the market in Asia Pacific to witness impressive growth. Increasing medical tourism in nations such as China and India will create lucrative growth opportunities for the market in the region. Besides this, increasing number of product innovations in the region backed by high presence of hereditary angioedema drugs manufacturers will give tailwinds to growth witnessed by the hereditary angioedema treatment market.

Request a Sample Copy of Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/hereditary-angioedema-treatment-market-100164

C-1 Esterase Inhibitor Segment to Dominate Global Market During Forecast Period

In terms of drug class, the C-1 esterase inhibitor is the most popular drug and dominated the global hereditary angioedema treatment market in 2017. The segment accounted for 61.3% of the global market in 2017. The trend is unlikely to change during the forecast period 2018-2025 owing to the drug’s reliability among patients and practitioners.

Increasing awareness about the disorder and rising prevalence of the hereditary angioedema are some factors expected to drive the global hereditary angioedema treatment market during the forecast period. Additionally, technological developments in the hereditary angioedema treatment devices and equipment is expected to boost the global market

About us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in. 

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.